Original document(78 pages)  中文版
    The invention relates to glucopyranosyl-substitutedted benzol derivatives of general formula (I), wherein rests R<1> to R<6> and R<7a>, R<7b>, R<7c> are such as defined in the claim 1, including the tautomers, stereoisomers, mixtures and the salts thereof. The inventive compounds are useful for treating metabolic diseases.
Application Number
申请号
200580006944 Application Date
申请日
2005.03.11
Title 名称 Glucopyranosyl-substituted benzol derivatives, drugs containing said compounds, the use thereof and method for the production thereof
Publication Number
公开号
1930141 Publication Date
公开日
2007.03.14
Approval Pub. Date Granted Pub. Date
International Classification 分类号 C07D309/10;A61K31/351
Applicant(s) Name
申请人
Boehringer Ingelheim Int
Address 地址
Inventor(s) Name 发明人
Attorney & Agent 代理人 fanmeng e wuxiao nan
More information 更  多  信  息


 Related patents information
Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
Biphenyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
Cyclic derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
Pyrimido [5,4-d] pyrimidines, medicaments containing these componds, their use and process for their production
4-amino pyrimidine derivates, medicament containing these compounds, their use
Pyrimido [5,4-D] pyrimidines, medicaments containing these compounds, their use and process for their production
Substituted phenylamidines with antithrombotic action
4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
Bicyclic heterocycles, medicaments contg. these compounds, their use and methods for prodn. thereof
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.